Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-01

Clinical Trial Update: Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial update on choline supplementation as a neurodevelopmental intervention in fetal alcohol spectrum disorders; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Choline supplementation (Choline)

Snippet

Sponsor: University of Minnesota | Conditions: Fetal Alcohol Spectrum Disorders | Phase 2 | Status: COMPLETED | Results posted: 2022-11-01